Journal
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Volume 485, Issue 2, Pages 174-182Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.abb.2009.02.010
Keywords
Ascorbate transport; Oxidant stress; RAW264.7 macrophages; Oxidized LDL; SVCT2; Dihydrofluorescein; Apoptosis; Malondialdehyde; Atherosclerosis; NF-kappa B
Categories
Funding
- NIH [DK 50435]
- Cell and Tissue Core of the Vanderbilt Diabetes Research and Training Center [DK 20593]
Ask authors/readers for more resources
To assess whether ascorbic acid decreases the cytotoxicity of oxidized human low density lipoprotein (oxLDL) in cells involved in atherosclerosis, its interaction with oxLDI. was studied in murine RAW264.7 macrophages. Macrophages took up ascorbate to millimolar intracellular concentrations and retained it with little loss over 18 h in Culture. Culture of the macrophages with oxLDL enhanced ascorbate uptake. This was associated with increased expression of the ascorbate transporter (SVCT2), which was prevented by ascorbate and by inhibiting the NF-kappa B pathway. Culture of RAW264.7 macrophages with oxLDL increased intracellular dihydrofluorescein oxidation and lipid peroxidation, both of which were decreased by intracellular ascorbate. Ascorbate also protected the cells against oxLDL-induced cytotoxicity and apoptosis, but it did not affect macrophage accumulation of lipid from oxLDL or oxLDL-induced increases in macrophage cytokine secretion. These results Suggest that ascorbate protects macrophages against oxLDL-induced oxidant stress and Subsequent apoptotic death without impairing their function. (C) 2009 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available